133 related articles for article (PubMed ID: 28588727)
1. Synergistic cytotoxic effects of a combined treatment of a
Zhang M; Yu Y; Zhang H; Huang H; Cai Q; Kang Y; Li G; Xu C
Oncol Lett; 2017 Jun; 13(6):4748-4754. PubMed ID: 28588727
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effects of a novel lipid-soluble extract from
Zhang M; Zhang H; Yu Y; Huang H; Li G; Xu C
Oncol Lett; 2017 Apr; 13(4):2121-2128. PubMed ID: 28454371
[TBL] [Abstract][Full Text] [Related]
3. A lipid-soluble extract of Pinellia pedatisecta Schott enhances antitumor T cell responses by restoring tumor-associated dendritic cell activation and maturation.
Wang Y; Huang H; Yao S; Li G; Xu C; Ye Y; Gui S
J Ethnopharmacol; 2019 Sep; 241():111980. PubMed ID: 31146000
[TBL] [Abstract][Full Text] [Related]
4. A lipid-soluble extract of Pinellia pedatisecta Schott orchestrates intratumoral dendritic cell-driven immune activation through SOCS1 signaling in cervical cancer.
Wang Y; Lu C; Huang H; Yao S; Xu C; Ye Y; Gui S; Li G
J Ethnopharmacol; 2021 Mar; 267():112837. PubMed ID: 32276009
[TBL] [Abstract][Full Text] [Related]
5. Immune modulation of a lipid-soluble extract of Pinellia pedatisecta Schott in the tumor microenvironment of an HPV
Huang H; Zhang M; Yao S; Zhang M; Peng J;
J Ethnopharmacol; 2018 Oct; 225():103-115. PubMed ID: 29783020
[TBL] [Abstract][Full Text] [Related]
6. HPV E6 down-regulation and apoptosis induction of human cervical cancer cells by a novel lipid-soluble extract (PE) from Pinellia pedatisecta Schott in vitro.
Li GL; Jiang W; Xia Q; Chen SH; Ge XR; Gui SQ; Xu CJ
J Ethnopharmacol; 2010 Oct; 132(1):56-64. PubMed ID: 20659543
[TBL] [Abstract][Full Text] [Related]
7. The synergistic therapeutic effect of cisplatin with Human papillomavirus E6/E7 short interfering RNA on cervical cancer cell lines in vitro and in vivo.
Jung HS; Erkin OC; Kwon MJ; Kim SH; Jung JI; Oh YK; Her SW; Ju W; Choi YL; Song SY; Kim JK; Kim YD; Shim GY; Shin YK
Int J Cancer; 2012 Apr; 130(8):1925-36. PubMed ID: 21630254
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effects of cisplatin-caffeic acid induces apoptosis in human cervical cancer cells via the mitochondrial pathways.
Koraneekit A; Limpaiboon T; Sangka A; Boonsiri P; Daduang S; Daduang J
Oncol Lett; 2018 May; 15(5):7397-7402. PubMed ID: 29731891
[TBL] [Abstract][Full Text] [Related]
9. Synergistic anticancer effect of combined use of Trichosanthes kirilowii with cisplatin and pemetrexed enhances apoptosis of H1299 non-small-cell lung cancer cells via modulation of ErbB3.
Ku JM; Hong SH; Kim HI; Kim MJ; Kim SK; Kim M; Choi SY; Park J; Kim HK; Kim JH; Seo HS; Shin YC; Ko SG
Phytomedicine; 2020 Jan; 66():153109. PubMed ID: 31790894
[TBL] [Abstract][Full Text] [Related]
10. Andrographolide sensitizes the cytotoxicity of human colorectal carcinoma cells toward cisplatin via enhancing apoptosis pathways in vitro and in vivo.
Lin HH; Shi MD; Tseng HC; Chen JH
Toxicol Sci; 2014 May; 139(1):108-20. PubMed ID: 24563380
[TBL] [Abstract][Full Text] [Related]
11. Combined treatment of marizomib and cisplatin modulates cervical cancer growth and invasion and enhances antitumor potential
Zhang Z; Zhang S; Lin B; Wang Q; Nie X; Shi Y
Front Oncol; 2022; 12():974573. PubMed ID: 36110967
[TBL] [Abstract][Full Text] [Related]
12. ZM447439, the Aurora kinase B inhibitor, suppresses the growth of cervical cancer SiHa cells and enhances the chemosensitivity to cisplatin.
Zhang L; Zhang S
J Obstet Gynaecol Res; 2011 Jun; 37(6):591-600. PubMed ID: 21159048
[TBL] [Abstract][Full Text] [Related]
13. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
Mizutani Y; Yoshida O; Bonavida B
J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
[TBL] [Abstract][Full Text] [Related]
14. Sensitization by glycerol for CDDP-therapy against human cultured cancer cells and tumors bearing mutated p53 gene.
Yuki K; Takahashi A; Ota I; Ohnishi K; Yasumoto J; Yane K; Kanata H; Okamoto N; Hosoi H; Ohnishi T
Apoptosis; 2004 Nov; 9(6):853-9. PubMed ID: 15505427
[TBL] [Abstract][Full Text] [Related]
15. Co-delivery of paclitaxel and TOS-cisplatin via TAT-targeted solid lipid nanoparticles with synergistic antitumor activity against cervical cancer.
Liu B; Han L; Liu J; Han S; Chen Z; Jiang L
Int J Nanomedicine; 2017; 12():955-968. PubMed ID: 28203075
[TBL] [Abstract][Full Text] [Related]
16. Synergism of cisplatin-oleanolic acid co-loaded calcium carbonate nanoparticles on hepatocellular carcinoma cells for enhanced apoptosis and reduced hepatotoxicity.
Khan MW; Zhao P; Khan A; Raza F; Raza SM; Sarfraz M; Chen Y; Li M; Yang T; Ma X; Xiang G
Int J Nanomedicine; 2019; 14():3753-3771. PubMed ID: 31239661
[No Abstract] [Full Text] [Related]
17. Synergistic antitumor effect of brusatol combined with cisplatin on colorectal cancer cells.
Chen HM; Lai ZQ; Liao HJ; Xie JH; Xian YF; Chen YL; Ip SP; Lin ZX; Su ZR
Int J Mol Med; 2018 Mar; 41(3):1447-1454. PubMed ID: 29328398
[TBL] [Abstract][Full Text] [Related]
18. Enhanced sensitivity of bladder cancer cells to cisplatin mediated cytotoxicity and apoptosis in vitro and in vivo by the selective cyclooxygenase-2 inhibitor JTE-522.
Mizutani Y; Nakanishi H; Li YN; Sato N; Kawauchi A; Miki T
J Urol; 2004 Oct; 172(4 Pt 1):1474-9. PubMed ID: 15371874
[TBL] [Abstract][Full Text] [Related]
19. The synergistic antitumor effect of cinobufagin and cisplatin in human osteosarcoma cell line
Dai G; Yu L; Yang J; Xia K; Zhang Z; Liu G; Gao T; Guo W
Oncotarget; 2017 Oct; 8(49):85150-85168. PubMed ID: 29156710
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II type 1 receptor antagonist enhances cis-dichlorodiammineplatinum-induced cytotoxicity in mouse xenograft model of bladder cancer.
Kosugi M; Miyajima A; Kikuchi E; Kosaka T; Horiguchi Y; Murai M; Oya M
Urology; 2009 Mar; 73(3):655-60. PubMed ID: 19167032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
